Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-06T07:15:30.289Z Has data issue: false hasContentIssue false
  • English
  • Français

Nasal disease and quality of life in athletes

Published online by Cambridge University Press:  31 August 2018

A C Walker ,
P Surda ,
M Rossiter  and
S A Little
A C Walker*
Affiliation:
Department of Otolaryngology, Guy's Hospital, London, UK
P Surda
Affiliation:
Department of Otolaryngology, Guy's Hospital, London, UK
M Rossiter
Affiliation:
Department of Sports Medicine, All Sports Medicine, Basingstoke, UK
S A Little
Affiliation:
Department of Otolaryngology, St George's Hospital, London, UK
*
Author for correspondence: Dr Abigail Walker, Department of Otolaryngology, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

Nasal disease imposes a significant disease burden upon the individual in the general population, but is relatively under studied in athletes. This study sought to define the frequency of nasal symptoms in the active population, and to quantify the impact of these symptoms on quality of life and on the frequency of upper respiratory tract infections.

Results

A total of 296 participants completed the study (246 athletes and 50 sedentary controls). Nasal symptoms were significantly more frequent in the active group than in the sedentary controls (70 per cent vs 52 per cent). Upper respiratory tract infections were significantly more common in athletes with regular nasal symptoms than in athletes without nasal symptoms. Quality-of-life scores, as measured by the 22-item Sino-Nasal Outcome Test, were significantly worse in athletes with regular nasal symptoms.

Conclusion

This study suggests that regular exercise is associated with a significant increase in the prevalence of troubling nasal symptoms, and nasal symptoms in athletes are associated with increased susceptibility to upper respiratory tract infections. Quality of life was negatively affected, confirming the importance of nasal health to athlete welfare.

Keywords

AthletesRhinitisHypersensitivityQuality Of Life
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 132 , Issue 9 , September 2018 , pp. 812 - 815
Copyright
Copyright © JLO (1984) Limited, 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr A Walker takes responsibility for the integrity of the content of the paper

Presented at the 26th Congress of the European Rhinologic Society, 3–7 July 2016, Stockholm, Sweden.

References

1Dallimore, N, Eccles, R. Changes in human nasal resistance associated with exercise, hyperventilation and rebreathing. Acta Otolaryngol 1977;84:416–21Google Scholar
2Bonini, M, Gramiccioni, C, Fioretti, D, Ruckert, B, Rinaldi, M, Akdis, C et al. Asthma, allergy and the Olympics: a 12-year survey in elite athletes. Curr Opin Allergy Clin Immunol 2015;15:184–92Google Scholar
3Katelaris, CH, Carrozzi, FM, Burke, TV, Byth, K. Patterns of allergic reactivity and disease in Olympic athletes. Clin J Sport Med 2006;16:401–5Google Scholar
4Kurowski, M, Jurczyk, J, Krysztofiak, H, Kowalski, ML. Exercise-induced respiratory symptoms and allergy in elite athletes: Allergy and Asthma in Polish Olympic Athletes (A2POLO) project within GA2LEN initiative. Clin Respir J 2014;10:231–8Google Scholar
5Bougault, V, Turmel, J, Boulet, LP. Effect of intense swimming training on rhinitis in high-level competitive swimmers. Clin Exp Allergy 2010;40:1238–46Google Scholar
6Bonadonna, P, Senna, G, Zanon, P, Cocco, G, Dorizzi, R, Dani, F et al. Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol 2001;15:297–301Google Scholar
7Thomas, S, Wolfarth, B, Wittmer, C, Nowak, D, Radon, K. Self-reported asthma and allergies in top athletes compared to the general population—results of the German part of the GA2LEN-Olympic study 2008. Allergy Asthma Clin Immunol 2010;6:31Google Scholar
8Wallace, DV, Dykewicz, MS, Bernstein, DI, Blessing-Moore, J, Cox, L, Khan, DA et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 suppl):S1–84Google Scholar
9Hopkins, C, Gillett, S, Slack, R, Lund, V, Browne, J. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009;34:447–54Google Scholar
10Bauchau, V, Durham, SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758–64Google Scholar
11Jones, N, Smith, P, Carney, A, Davis, A. The prevalence of allergic rhinitis and nasal symptoms in Nottingham. Clin Otolaryngol 1998;23:547–54Google Scholar
12Patil, VK, Kurukulaaratchy, RJ, Venter, C, Grundy, J, Roberts, G, Dean, T et al. Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart. Clin Exp Allergy 2015;45:1430–8Google Scholar
13Scadding, GK, Kariyawasam, H, Scadding, G, Mirakian, R, Buckley, RJ, Dixon, T et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; 2007). Clin Exp Allergy 2017;47:856–89Google Scholar
14World Anti-Doping Agency. Prohibited List Documents. In: https://www.wada-ama.org/en/resources/science-medicine/prohibited-list-documents [25 July 2018]Google Scholar
15Nieman, DC. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc 1994;26:128–39Google Scholar
16Reeser, JC, Willick, S, Elstad, M. Medical services provided at the Olympic village polyclinic during the 2002 Salt Lake City Winter Games. WMJ 2003;102:20–5Google Scholar
17Engebretsen, L, Soligard, T, Steffen, K, Alonso, JM, Aubry, M, Budgett, R et al. Sports injuries and illnesses during the London Summer Olympic Games 2012. Br J Sports Med 2013;47:407–14Google Scholar
18Spence, L, Brown, WJ, Pyne, DB, Nissen, MD, Sloots, TP, McCormack, JG et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med Sci Sports Exerc 2007;39:577–86Google Scholar
19Robson-Ansley, P, Howatson, G, Tallent, J, Mitcheson, K, Walshe, I, Toms, C et al. Prevalence of allergy and upper respiratory tract symptoms in runners of the London marathon. Med Sci Sports Exerc 2012;44:999–1004Google Scholar
20Katelaris, CH, Carrozzi, FM, Burke, TV, Byth, K. Effects of intranasal budesonide on symptoms, quality of life, and performance in elite athletes with allergic rhinoconjunctivitis. Clin J Sport Med 2002;12:296–300Google Scholar